main-logo

ICD-10 Code C91.12 | Chronic lymphocytic leukemia of B-cell type in relapse Symptoms, Diagnosis, Billing

Chronic lymphocytic leukemia (CLL) of B-cell type in relapse is a hematological malignancy characterized by the accumulation of functionally incompetent B-lymphocytes. This condition is clinically significant as it often leads to progressive disease, requiring careful monitoring and treatment adjustments. The ICD-10 Code C91.12 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage patient care and track disease prevalence.

What is ICD-10 Code C91.12 for Chronic lymphocytic leukemia of B-cell type in relapse?

ICD-10 Code C91.12 represents Chronic lymphocytic leukemia of B-cell type in relapse, indicating a return of the disease after a period of remission. This code is used when documenting the patient's clinical status, particularly when the disease has progressed or recurred, ensuring appropriate treatment plans and billing practices are followed.

ICD-10 Code C91.12 – Clinical Definition and Explanation of Chronic lymphocytic leukemia of B-cell type in relapse

Chronic lymphocytic leukemia of B-cell type in relapse occurs when previously treated CLL returns, often leading to increased lymphocyte counts and symptomatic manifestations. This condition necessitates prompt medical intervention due to its potential complications and impact on patient quality of life.

Key Clinical Features:

  • Elevated lymphocyte count on complete blood count (CBC).
  • Lymphadenopathy or splenomegaly upon physical examination.
  • Symptoms such as fatigue, weight loss, and recurrent infections.
  • Potential transformation to a more aggressive form of leukemia.

ICD-10 Code C91.12 for Chronic lymphocytic leukemia of B-cell type in relapse – SOAP Notes & Clinical Use

ICD-10 Code C91.12 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is essential for both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing accuracy.

What Does ICD-10 Code C91.12 for Chronic lymphocytic leukemia of B-cell type in relapse Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C91.12 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of CLL in relapse. This code is crucial for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C91.12 – Chronic lymphocytic leukemia of B-cell type in relapse

Management of Chronic lymphocytic leukemia of B-cell type in relapse requires a multidisciplinary approach, often involving chemotherapy, targeted therapy, or immunotherapy. Hospitalization may be necessary for severe cases.

Antibiotic Therapy:

  • Not typically indicated unless there is an infection; consider prophylactic antibiotics in immunocompromised patients.
  • First-line: Ciprofloxacin 500 mg orally twice daily for 7-14 days.
  • Alternative: Trimethoprim-sulfamethoxazole 160/800 mg orally daily for 7-14 days.

Supportive Care:

  • Management of anemia with erythropoiesis-stimulating agents.
  • Transfusion support for severe thrombocytopenia.
  • Nutritional support and counseling to address weight loss.

Infection Control:

  • Implement strict hand hygiene protocols.
  • Use of masks and isolation precautions during outbreaks.
  • Regular monitoring for signs of infection in immunocompromised patients.

How to Document Symptoms of Chronic lymphocytic leukemia of B-cell type in relapse (ICD-10 C91.12) in SOAP Notes

Subjective:

  • Patient reports increased fatigue and unintentional weight loss.
  • History of recurrent infections over the past few months.
  • Notable increase in lymph node size as reported by the patient.

Objective:

  • CBC shows elevated lymphocyte count of 15,000 cells/µL.
  • Physical examination reveals palpable lymphadenopathy in cervical and axillary regions.
  • Splenomegaly noted on abdominal examination.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Chronic lymphocytic leukemia of B-cell type in relapse (ICD-10 Code C91.12)

Assessment:

  • Diagnosis: Chronic lymphocytic leukemia of B-cell type in relapse, moderate severity.
  • ICD-10 Code: C91.12.
  • Contributing factors include previous treatment history and current symptomatic presentation.

Plan:

  • Initiate treatment with targeted therapy (e.g., ibrutinib).
  • Educate patient on signs of infection and when to seek care.
  • Schedule follow-up appointments every 4-6 weeks for monitoring.

Treatment & Plan Section for ICD-10 Code C91.12 – Chronic lymphocytic leukemia of B-cell type in relapse

  • First-line treatment may include targeted therapies such as ibrutinib or venetoclax.
  • Non-pharmacologic strategies include nutritional support and psychosocial counseling.
  • Regular monitoring of blood counts and disease progression through imaging.
  • Follow-up visits should be scheduled to assess treatment response and adjust therapy as needed.

Using ICD-10 Code C91.12 for Chronic lymphocytic leukemia of B-cell type in relapse in Billing & SOAP Note Compliance

  • Select appropriate ICD-10 codes based on clinical documentation of relapse.
  • Ensure Subjective (S) and Objective (O) sections clearly reflect the patient's symptoms and clinical findings.
  • Align treatment plans with clinical guidelines to support justified billing.
  • Include relevant CPT codes that correspond to the services provided during the visit.

ICD-10 Code C91.12 in Medical Billing and Insurance for Chronic lymphocytic leukemia of B-cell type in relapse

ICD-10 Code C91.12 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.

Billing Notes:

  • Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
  • Use this code in conjunction with other relevant codes for comprehensive billing.
  • Ensure that the documentation reflects the severity and complexity of the patient's condition.

Common CPT Pairings:

CPT CodeDescription
96413Chemotherapy administration, intravenous, push, single or initial substance.
36415Collection of venous blood by venipuncture.
99214Established patient office visit, moderate complexity.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C91.12 for Chronic lymphocytic leukemia of B-cell type in relapse

What are the common symptoms of Chronic lymphocytic leukemia of B-cell type in relapse?

Common symptoms include fatigue, weight loss, night sweats, and recurrent infections. Patients may also experience lymphadenopathy and splenomegaly.

How is Chronic lymphocytic leukemia of B-cell type in relapse treated?

Treatment may involve targeted therapies, chemotherapy, or immunotherapy, depending on the patient's overall health and disease progression.

When should ICD-10 Code C91.12 be used?

This code should be used when documenting a relapse of Chronic lymphocytic leukemia of B-cell type, particularly after a period of remission.

What is the importance of accurate coding for C91.12?

Accurate coding ensures proper reimbursement, facilitates appropriate treatment planning, and supports public health data collection.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved